These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research. Chege GK; Williamson AL; Passmore JS; Bourn W; Ryffel B; Shephard EG Vaccine; 2005 Dec; 23(50):5783-91. PubMed ID: 16214269 [TBL] [Abstract][Full Text] [Related]
29. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Langermans JA; Andersen P; van Soolingen D; Vervenne RA; Frost PA; van der Laan T; van Pinxteren LA; van den Hombergh J; Kroon S; Peekel I; Florquin S; Thomas AW Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11497-502. PubMed ID: 11562492 [TBL] [Abstract][Full Text] [Related]
30. Development of a Mycobacterium bovis intranasal challenge model in mice. Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980 [TBL] [Abstract][Full Text] [Related]
31. Vaccination of cattle against Mycobacterium bovis. Buddle BM Tuberculosis (Edinb); 2001; 81(1-2):125-32. PubMed ID: 11463233 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
33. Update on vaccination of cattle and wildlife populations against tuberculosis. Buddle BM; Wedlock DN; Denis M; Vordermeier HM; Hewinson RG Vet Microbiol; 2011 Jul; 151(1-2):14-22. PubMed ID: 21420804 [TBL] [Abstract][Full Text] [Related]
34. The use of mutant mycobacteria as new vaccines to prevent tuberculosis. Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875 [TBL] [Abstract][Full Text] [Related]
35. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
36. Clinical Testing of Tuberculosis Vaccine Candidates. Hatherill M; Tait D; McShane H Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 28087924 [TBL] [Abstract][Full Text] [Related]
37. Vaccination against tuberculosis: how can we better BCG? Pitt JM; Blankley S; McShane H; O'Garra A Microb Pathog; 2013 May; 58():2-16. PubMed ID: 23257069 [TBL] [Abstract][Full Text] [Related]
38. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy. Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843 [TBL] [Abstract][Full Text] [Related]
39. Persistence of Mycobacterium bovis Bacillus Calmette-Guérin in white-tailed deer (Odocoileus virginianus) after oral or parenteral vaccination. Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Lebepe-Mazur SM; Harris NB Zoonoses Public Health; 2010 Dec; 57(7-8):e206-12. PubMed ID: 20707863 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains]. Prygiel M; Janaszek-Seydlitz W; Bucholc B Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]